CALR and carcinoma: In agreement with the data of others [10, 16], CTX-IR700 photoimmunotherapy-treated carcinoma cells demonstrated an apparent increase in surface expression of Hsp70, Hsp90, and CRT, as observed by flow cytometry (Supplementary Fig. S2A).